Dr. Janina Gergen

Senior Research Scientist with a background in infection biology, experienced in vaccine research and development, responsible for vaccine candidate design, in vitro characterization and immunogenicity assessment. Leads complex R&D projects including budget responsibility and timeline planning. Closely working with cross-functional teams, managing activities at CROs and collaborating with external partners. Skilled in translating data into scientific insights and presenting results to stakeholders.

• Development of an anti-viral CRISPR/Cas9 systems against the human Cytomegalovirus • Sequence analysis and guideRNA design • Planning, execution and data interpretation of in vitro experiments • Hands-on experience in virological methods: virus production, infection assay, viral vectors • first-author scientific publication, patent application • Oral and poster presentations at 6 scientific conferences

Immunologie, Virologie, Mikrobiologie praktische Erfahrungen: CRISPR/Cas9 (Gentechnik), FACS, Luziferase-assay, Transfektion, Zellkultur

Infektionsbiologie: Immunologie, Virologie praktische Erfahrung: Virus Produktion, Aufreinigung und Infektion in Zellkultur, SDS-PAGE/Western Blot

Note: 1,3